Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

725 public trials 133 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Active, Not Recruiting

Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM)

NCT06294236

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +33 more
Locations
  • University of Colorado Aurora, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT05321420

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +6 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Science 37 Los Angeles, California, United States
  • NewportNativeMD, Inc. Newport Beach, California, United States
  • Paradigm Clinical Research Centers, Inc. Redding, California, United States
View all 103 locations
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

NCT05732402

Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis, Autoimmune Diseases, +38 more
Locations
  • Investigational Site (523) Phoenix, Arizona, United States
  • Investigational Site (501) Phoenix, Arizona, United States
  • Investigational Site (524) Tucson, Arizona, United States
  • Investigational Site (506) Valencia, California, United States
View all 30 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of XTD Regimen (Selinexor, Thalidomide and Dexamethasone) in Adult Patients With Relapsed/Refractory LCH

NCT07204041

Conditions
Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +5 more
Locations
  • Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing, Beijing, China
View Trial Details

Related conditions